作者
- Adams, K.F. (18)
- Elkayam, U. (4)
- Frey, A. (4)
- Fuzaylov, S.F. (4)
- Gattis, W.A. (41)
- Gheorghiade, M. (27)
- Gurbel, P.A. (4)
- Hasselblad, V. (7)
- Massie, B.M. (4)
- O'Connor, C.M. (39)
|
總筆數:41
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Current and novel pharmacologic approaches in advanced heart failure |
O'Connor, C.M.;Gattis, W.A.;Swedberg, K.; |
American Heart Journal |
1998-06-01 |
查看 |
| Is optimal angiotensin-converting enzyme inhibitor dosing neglected inelderly patients with heart failure? |
Gattis, W.A.;Larsen, R.L.;Hasselblad, V.;Bart, B.A.;O'Connor, C.M.; |
American Heart Journal |
1998-07-01 |
查看 |
| Is optimal angiotensin-converting enzyme inhibitor dosing neglected inelderly patients with heart failure? |
Gattis, W.A.;Larsen, R.L.;Hasselblad, V.;Bart, B.A.;O'Connor, C.M.; |
American Heart Journal |
1998-07-01 |
查看 |
| Continuous intravenous dobutamine is associated with an increased riskof death in patients with advanced heart failure: Insights from the FlolanInternational Randomized Survival Trial (FIRST) |
For the FIRST Investigators;O'Connor, C.M.;Gattis, W.A.;Uretsky, B.F.;Adams, K.F.;McNulty, S.E.;Grossman, S.H.;McKenna, W.J.;Zannad, F.;Swedberg, K.;Gheorghiade, M.;Califf, R.M.; |
American Heart Journal |
1999-07-01 |
查看 |
| Continuous intravenous dobutamine is associated with an increased riskof death in patients with advanced heart failure: Insights from the FlolanInternational Randomized Survival Trial (FIRST) |
For the FIRST Investigators;O'Connor, C.M.;Gattis, W.A.;Uretsky, B.F.;Adams, K.F.;McNulty, S.E.;Grossman, S.H.;McKenna, W.J.;Zannad, F.;Swedberg, K.;Gheorghiade, M.;Califf, R.M.; |
American Heart Journal |
1999-07-01 |
查看 |
| A randomized trial of ecadotril versus placebo in patients with mild tomoderate heart failure: The U.S. Ecadotril Pilot Safety Study |
For the U.S. Ecadotril Investigators;O'Connor, C.M.;Gattis, W.A.;Gheorghiade, M.;Granger, C.B.;Gilbert, J.;McKenney, J.M.;Messineo, F.C.;Burnett, J.C.;Katz, S.D.;Elkayam, U.;Kasper, E.K.;Goldstein, S.;Cody, R.J.;Massie, B.M.; |
American Heart Journal |
1999-12-01 |
查看 |
| A randomized trial of ecadotril versus placebo in patients with mild tomoderate heart failure: The U.S. Ecadotril Pilot Safety Study |
For the U.S. Ecadotril Investigators;O'Connor, C.M.;Gattis, W.A.;Gheorghiade, M.;Granger, C.B.;Gilbert, J.;McKenney, J.M.;Messineo, F.C.;Burnett, J.C.;Katz, S.D.;Elkayam, U.;Kasper, E.K.;Goldstein, S.;Cody, R.J.;Massie, B.M.; |
American Heart Journal |
1999-12-01 |
查看 |
| The role of clinical nonfatal end points in cardiovascular phase II/IIIclinical trials |
O'Connor, C.M.;Gattis, W.A.;Ryan, T.J.; |
American Heart Journal |
2000-04-01 |
查看 |
| Angiotensin-converting enzyme inhibitor dosing in heart failure: What isoptimal? |
Gattis, W.A.;Galanos, A.;O'Connor, C.M.; |
American Heart Journal |
2001-03-01 |
查看 |
| Angiotensin-converting enzyme inhibitor dosing in heart failure: What isoptimal? |
Gattis, W.A.;Galanos, A.;O'Connor, C.M.; |
American Heart Journal |
2001-03-01 |
查看 |
| Evaluation of platelets in heart failure: Is platelet activity related toetiology, functional class, or clinical outcomes? |
Gurbel, P.A.;Gattis, W.A.;Fuzaylov, S.F.;Gaulden, L.;Hasselblad, V.;Serebruany, V.L.;O'Connor, C.M.; |
American Heart Journal |
2002-06-01 |
查看 |
| Evaluation of platelets in heart failure: Is platelet activity relatedto etiology, functional class, or clinical outcomes? |
Gurbel, P.A.;Gattis, W.A.;Fuzaylov, S.F.;Gaulden, L.;Hasselblad, V.;Serebruany, V.L.;O'Connor, C.M.; |
American Heart Journal |
2002-06-01 |
查看 |
| Evaluation of platelets in heart failure: Is platelet activity relatedto etiology, functional class, or clinical outcomes? |
Gurbel, P.A.;Gattis, W.A.;Fuzaylov, S.F.;Gaulden, L.;Hasselblad, V.;Serebruany, V.L.;O'Connor, C.M.; |
American Heart Journal |
2002-06-01 |
查看 |
| Evaluation of platelets in heart failure: Is platelet activity relatedto etiology, functional class, or clinical outcomes? |
Gurbel, P.A.;Gattis, W.A.;Fuzaylov, S.F.;Gaulden, L.;Hasselblad, V.;Serebruany, V.L.;O'Connor, C.M.; |
American Heart Journal |
2002-06-01 |
查看 |
| Tezosentan in patients with acute heart failure and acute coronarysyndromes: Design of the Randomized Intravenous Tezosentan Study (RITZ-4) |
O'Connor, C.M.;Gattis, W.A.;Adams, K.F.;Shah, M.R.;Kobrin, I.;Frey, A.;Gheorghiade, M.;RITZ-4 Investigators; |
American Heart Journal |
2002-10-01 |
查看 |
| Tezosentan in patients with acute heart failure and acute coronarysyndromes: Design of the Randomized Intravenous Tezosentan Study (RITZ-4) |
O'Connor, C.M.;Gattis, W.A.;Adams, K.F.;Shah, M.R.;Kobrin, I.;Frey, A.;Gheorghiade, M.;RITZ-4 Investigators; |
American Heart Journal |
2002-10-01 |
查看 |
| Introduction |
Gheorghiade, M.;Gattis, W.A.;O'Connor, C.M.;Adams, K.F.; |
American Heart Journal |
2003-02-01 |
查看 |
| Current medical treatment for the exacerbation of chronic heart failureresulting in hospitalization |
Jain, P.;Massie, B.M.;Gattis, W.A.;Klein, L.;Gheorghiade, M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Design considerations and proposed template for clinical trials inhospitalized patients with decompensated chronic heart failure |
O'Connor, C.M.;Gattis, W.A.;Teerlink, J.R.;Adams, K.F.;Gheorghiade, M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Rationale and study design for a multicenter, randomized, double-blind,placebo-controlled study of the effects of tolvaptan on the acute andchronic outcomes of patients hospitalized with worsening congestive heartfailure |
Gheorghiade, M.;Gattis, W.A.;Barbagelata, A.;Adams, K.F.;Elkayam, U.;Orlandi, C.;O'Connor, C.M.;Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in;Congestive Heart Failure (ACTIV in CHF) Investigators; |
American Heart Journal |
2003-02-01 |
查看 |
| Rationale and design of the pilot randomized study of nesiritide versusdobutamine in heart failure (PRESERVD-HF) |
Gheorghiade, M.;Gattis, W.A.;Adams, K.F.;Jaffe, A.S.;O'Connor, C.M.;Duke University Cooperative Cardiovascular Studies (DUCCS) Investigators; |
American Heart Journal |
2003-02-01 |
查看 |
| Tezosentan in patients with acute heart failure and acute coronarysyndromes: Design of the fourth Randomized Intravenous Tezosentan Study(RITZ-4) |
O'Connor, C.M.;Gattis, W.A.;Adams, K.F.;Shah, M.R.;Frey, A.;Gheorghiade, M.;RITZ-4 Investigators; |
American Heart Journal |
2003-02-01 |
查看 |
| Rationale and design of the Initiation Management Predischarge: Process forAssessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study |
Gheorghiade, M.;Gattis, W.A.;Lukas, M.A.;O'Connor, C.M.;IMPACT-HF Investigators; |
American Heart Journal |
2003-02-01 |
查看 |
| Concomitant use of a positive inotropic agent to create a bridge to thesuccessful initiation of @b-blocker therapy in patients with heart failure:A proposal for a trial |
Zampino, M.;O'Connor, C.M.;Gattis, W.A.;Adams, K.F.;Gheorghiade, M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Surrogate end points in heart failure trials |
Gheorghiade, M.;Adams, K.F.;Gattis, W.A.;Teerlink, J.R.;Orlandi, C.;O'Connor, C.M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Rationale and design of the Initiation Management Predischarge: Processfor Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study |
IMPACT-HF Investigators;Gheorghiade, M.;Gattis, W.A.;Lukas, M.A.;O'Connor, C.M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Concomitant use of a positive inotropic agent to create a bridge to thesuccessful initiation of @b-blocker therapy in patients with heart failure:A proposal for a trial |
Zampino, M.;O'Connor, C.M.;Gattis, W.A.;Adams, K.F.;Gheorghiade, M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Surrogate end points in heart failure trials |
Gheorghiade, M.;Adams, K.F.;Gattis, W.A.;Teerlink, J.R.;Orlandi, C.;O'Connor, C.M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Introduction |
Gheorghiade, M.;Gattis, W.A.;O'Connor, C.M.;Adams, K.F.; |
American Heart Journal |
2003-02-01 |
查看 |
| Current medical treatment for the exacerbation of chronic heart failureresulting in hospitalization |
Jain, P.;Massie, B.M.;Gattis, W.A.;Klein, L.;Gheorghiade, M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Design considerations and proposed template for clinical trials inhospitalized patients with decompensated chronic heart failure |
O'Connor, C.M.;Gattis, W.A.;Teerlink, J.R.;Adams, K.F.;Gheorghiade, M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Rationale and study design for a multicenter, randomized, double-blind,placebo-controlled study of the effects of tolvaptan on the acute andchronic outcomes of patients hospitalized with worsening congestive heartfailure |
Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in;Congestive Heart Failure (ACTIV in CHF) Investigators;Gheorghiade, M.;Gattis, W.A.;Barbagelata, A.;Adams, K.F.;Elkayam, U.;Orlandi, C.;O'Connor, C.M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Rationale and design of the pilot randomized study of nesiritide versusdobutamine in heart failure (PRESERVD-HF) |
Duke University Cooperative Cardiovascular Studies (DUCCS) Investigators;Gheorghiade, M.;Gattis, W.A.;Adams, K.F.;Jaffe, A.S.;O'Connor, C.M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Tezosentan in patients with acute heart failure and acute coronarysyndromes: Design of the fourth Randomized Intravenous Tezosentan Study(RITZ-4) |
RITZ-4 Investigators;O'Connor, C.M.;Gattis, W.A.;Adams, K.F.;Shah, M.R.;Frey, A.;Gheorghiade, M.; |
American Heart Journal |
2003-02-01 |
查看 |
| Implications of elevated cardiac troponin t in ambulatory patients withheart failure: a prospective analysis |
Hudson, M.P.;O'Connor, C.M.;Gattis, W.A.;Tasissa, G.;Hasselblad, V.;Holleman, C.M.;Gaulden, L.H.;Sedor, F.;Ohman, E.M.; |
American Heart Journal |
2004-03-01 |
查看 |
| Organized program to initiate lifesaving treatment in hospitalized patientswith heart failure (OPTIMIZE-HF): rationale and design |
Fonarow, G.C.;Abraham, W.T.;Albert, N.M.;Gattis, W.A.;Gheorghiade, M.;Greenberg, B.;O'Connor, C.M.;Yancy, C.W.;Young, J.; |
American Heart Journal |
2004-07-01 |
查看 |
| Racial differences in the outcomes of patients with diastolic heart failure |
East, M.A.;Peterson, E.D.;Shaw, L.K.;Gattis, W.A.;O'Connor, C.M.; |
American Heart Journal |
2004-07-01 |
查看 |
| Organized program to initiate lifesaving treatment in hospitalized patientswith heart failure (OPTIMIZE-HF): rationale and design |
Fonarow, G.C.;Abraham, W.T.;Albert, N.M.;Gattis, W.A.;Gheorghiade, M.;Greenberg, B.;O'Connor, C.M.;Yancy, C.W.;Young, J.; |
American Heart Journal |
2004-07-01 |
查看 |
| Racial differences in the outcomes of patients with diastolic heart failure |
East, M.A.;Peterson, E.D.;Shaw, L.K.;Gattis, W.A.;O'Connor, C.M.; |
American Heart Journal |
2004-07-01 |
查看 |
| Organized program to initiate lifesaving treatment in hospitalized patientswith heart failure (OPTIMIZE-HF): rationale and design |
Fonarow, G.C.;Abraham, W.T.;Albert, N.M.;Gattis, W.A.;Gheorghiade, M.;Greenberg, B.;O'Connor, C.M.;Yancy, C.W.;Young, J.; |
American Heart Journal |
2004-07-01 |
查看 |
| Racial differences in the outcomes of patients with diastolic heart failure |
East, M.A.;Peterson, E.D.;Shaw, L.K.;Gattis, W.A.;O'Connor, C.M.; |
American Heart Journal |
2004-07-01 |
查看 |
|
|
|
